case_images: PMC10601768_01
case_images: Treatment overview. NGS, next-generation sequencing; Tem/Cap, temozolomide/capecitabine; XELOX, oxaliplatin/capecitabine.
case_images: cro-2023-0016-0001-533198_F01.jpg
case_images: PMC10601768_01_cro-2023-0016-0001-533198_F01.jpg
case_images: F1
case_images: A treatment overview is shown in Figure 1.
case_images: PET/MRI. a PET/MRI fusion coronal June 2021. b PET/MRI fusion coronal March 2022. c Liver MRI T2-sequence June 2021. d Liver MRI T2-sequence March 2022.
case_images: cro-2023-0016-0001-533198_F02.jpg
case_images: PMC10601768_01_cro-2023-0016-0001-533198_F02.jpg
case_images: F2
case_images: Restaging with 68Ga-Dotatate PET/MRI was performed 8 weeks, 5 and 8 months after PRRT, showing a significant decrease in the extended liver metastases (percentage change baseline to current: 28), see Figure 2.